Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_3
1
20%
Ph phase_2
4
80%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)

Detailed Status

Completed2
Recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (80.0%)
Phase 31 (20.0%)

Trials by Status

recruiting120%
withdrawn120%
completed240%
terminated120%

Recent Activity

1 active trials
Showing 5 of 5
completedphase_2

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

NCT04306393
recruitingphase_3

Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass

NCT06702553
completedphase_2

Inhaled NO in Surgical Patients With Recent COVID-19 Infection

NCT05721144
withdrawnphase_2

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.

NCT04290871
terminatedphase_2

Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED

NCT04338828

Clinical Trials (5)

Showing 5 of 5 trials
NCT04306393Phase 2

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

Completed
NCT06702553Phase 3

Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass

Recruiting
NCT05721144Phase 2

Inhaled NO in Surgical Patients With Recent COVID-19 Infection

Completed
NCT04290871Phase 2

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.

Withdrawn
NCT04338828Phase 2

Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED

Terminated

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5